Patriot Financial Group Insurance Agency’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $309K | Buy |
2,035
+329
| +19% | +$49.9K | 0.04% | 397 |
|
|
2025
Q1 | $257K | Buy |
1,706
+194
| +13% | +$29.2K | 0.03% | 406 |
|
|
2024
Q4 | $279K | Sell |
1,512
-109
| -7% | -$20.1K | 0.04% | 382 |
|
|
2024
Q3 | $319K | Sell |
1,621
-66
| -4% | -$13K | 0.04% | 373 |
|
|
2024
Q2 | $349K | Buy |
1,687
+379
| +29% | +$78.3K | 0.05% | 333 |
|
|
2024
Q1 | $354K | Buy |
1,308
+182
| +16% | +$49.3K | 0.06% | 325 |
|
|
2023
Q4 | $266K | Buy |
1,126
+61
| +6% | +$14.4K | 0.05% | 363 |
|
|
2023
Q3 | $209K | Buy |
+1,065
| New | +$209K | 0.04% | 411 |
|
|
2022
Q3 | – | Sell |
-308
| Closed | -$66K | – | 711 |
|
|
2022
Q2 | $66K | Buy |
308
+13
| +4% | +$2.79K | 0.01% | 645 |
|
|
2022
Q1 | $84K | Sell |
295
-5
| -2% | -$1.42K | 0.02% | 628 |
|
|
2021
Q4 | $113K | Buy |
300
+9
| +3% | +$3.39K | 0.02% | 620 |
|
|
2021
Q3 | $120K | Sell |
291
-2
| -0.7% | -$825 | 0.02% | 586 |
|
|
2021
Q2 | $108K | Buy |
293
+35
| +14% | +$12.9K | 0.02% | 599 |
|
|
2021
Q1 | $75K | Buy |
258
+25
| +11% | +$7.27K | 0.02% | 643 |
|
|
2020
Q4 | $58K | Sell |
233
-1
| -0.4% | -$249 | 0.01% | 647 |
|
|
2020
Q3 | $53K | Sell |
234
-77
| -25% | -$17.4K | 0.02% | 528 |
|
|
2020
Q2 | $54K | Buy |
311
+3
| +1% | +$521 | 0.02% | 499 |
|
|
2020
Q1 | $39K | Buy |
308
+306
| +15,300% | +$38.7K | 0.02% | 503 |
|
|
2019
Q4 | $0 | Sell |
2
-4
| -67% | – | ﹤0.01% | 1334 |
|
|
2019
Q3 | $1K | Hold |
6
| – | – | ﹤0.01% | 1161 |
|
|
2019
Q2 | $1K | Sell |
6
-2
| -25% | -$333 | ﹤0.01% | 1203 |
|
|
2019
Q1 | $1K | Hold |
8
| – | – | ﹤0.01% | 1085 |
|
|
2018
Q4 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 882 |
|
|
2018
Q2 | – | Sell |
-27
| Closed | -$3K | – | 650 |
|
|
2018
Q1 | $3K | Hold |
27
| – | – | ﹤0.01% | 811 |
|
|
2017
Q4 | $3K | Hold |
27
| – | – | ﹤0.01% | 805 |
|
|
2017
Q3 | $3K | Buy |
+27
| New | +$3K | ﹤0.01% | 769 |
|